Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical and Translational Radiation Oncology|July 26, 2019
The role of biological dose-escalation for pancreatic cancerAnna M E Bruynzeel, Frank J Lagerwaard
Frontiers in Oncology|May 28, 2021
Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell CarcinomaBrian Keller, Anna M E Bruynzeel, Chad Tang, et al.
Cardiovascular Toxicology|July 27, 2007
Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trialsAalt Bast, Guido R M M Haenen, Anna M E Bruynzeel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancerOmar Bohoudi, Anna M E Bruynzeel, Shyama Tetar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2016
Isotoxic radiosurgery planning for brain metastasesOmar Bohoudi, Anna M E Bruynzeel, Frank J Lagerwaard, et al.
BMC Cancer|July 27, 2017
Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trialJaap D Zindler, Anna M E Bruynzeel, Daniëlle B P Eekers, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancerShyama U Tetar, Anna M E Bruynzeel, Frank J Lagerwaard, et al.
Cancer Chemotherapy and Pharmacology|December 21, 2006
Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in miceAnna M E Bruynzeel, Suzanne Vormer-Bonne, Aalt Bast, et al.
Clinical and Translational Radiation Oncology|October 27, 2025
Re-irradiation of adrenal metastases using MR-guided adaptive SABR: A feasible and effective approach in a high-risk populationMiguel A Palacios, Anna M E Bruynzeel, Peter S N van Rossum, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at riskFamke L Schneiders, Claire van Vliet, Nicolas Giraud, et al.
Pageof 6